INTERNATIONAL PATENT: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI FILES APPLICATION FOR "COMBINATION OF IL-1 RECEPTOR INHIBITORS, ANTI PD-1 AND IL-4 INHIBITORS IN THE TREATMENT OF CANCER"

GENEVA, Nov. 18 -- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (One Gustave L. Levy PlaceNew York, New York 10029) filed a patent application (PCT/US2025/027066) for "COMBINATION OF IL-1 RECEPTOR INHIBITORS, ANTI PD-1, AND IL-4 INHIBITORS IN THE TREATMENT OF CANCER" on Apr 30, 2025. With publication no. WO/2025/235276, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PARK, Matthew Dae-Young (c/o Icahn School of Medicine at Mount SinaiOne Gustave L. Levy PlaceNew York, New York 10029), MERAD, Miriam (c/o Icahn School of Medicin...